1 Min Read
March 1 (Reuters) - Perrigo Company Plc
* Perrigo announces FDA final approval for the generic version of Axiron topical solution, 30 mg/1.5 ml Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.